NeuroOne Medical Technologies CorporationNMTCNASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank29
3Y CAGR-73.5%
5Y CAGR-22.9%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
-73.5%/yr
Annual compound
5Y CAGR
-22.9%/yr
Recent deceleration
Percentile
P29
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
4 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 2.95 | -61.6% |
| 2024 | 7.67 | -7.2% |
| 2023 | 8.26 | -94.8% |
| 2022 | 157.96 | -33.4% |
| 2021 | 237.18 | +2086.0% |
| 2020 | 10.85 | - |
| 2019 | 0.00 | - |
| 2018 | 0.00 | - |
| 2017 | 0.00 | - |
| 2016 | 0.00 | - |